Previous 10 | Next 10 |
Windtree TherapeuticS press release (NASDAQ:WINT): FY GAAP EPS of -$2.73 misses by $0.17. As of December 31, 2021, the Company reported cash and cash equivalents of $22.3 million. For further details see: Windtree TherapeuticS GAAP EPS of -$2.73 misses by $0.17
WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today reported financial results for the fourth quarter and year...
WARRINGTON, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced results from its Phase 2 study of lucinactant (K...
United Time Technology (UTME) +46%. BT Brands (BTBD) +37%. O2Micro International (OIIM) +31%. Anaplan (PLAN) +28% Thoma Bravo agrees to buy Anaplan for $10.7B. Vinco Ventures (BBIG) +22%. Marine Petroleum (MARPS) +21%. Mullen Automotive (MULN) +20%. Cuentas (CUEN) +14% pa...
WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its ...
WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, President ...
Gainers: Dave (NASDAQ:DAVE) +37%. Windtree Therapeutics (NASDAQ:WINT) +24%. BioRestorative Therapies (NASDAQ:BRTX) +19%. Creative Realities (NASDAQ:CREX) +19%. Biofrontera (NASDAQ:BFRI) +18%. voxeljet (NASDAQ:VJET) +18%. Immunic (NASDAQ:IMUX) +18%. Digihost Technology (NASDAQ:DGHI) +17%. Hype...
Windtree Therapeutics (WINT) completed enrollment in its phase 2 study of lucinactant (KL4 surfactant) for patients with COVID-19 associated lung injury and acute respiratory distress syndrome (ARDS). Data is expected in Q1. The trial enrolled 20 patients to evaluate the safety and tolerabili...
AMC Entertainment Holdings (NYSE:AMC) +14% as preliminary Q4 revenue tops consensus. Wallbox (NYSE:WBX) +14% Uber and Wallbox to expand partnership to all of the U.S. Spire Global (NYSE:SPIR) +10% as preliminary Q4 revenue soars 111% Y/Y. ObsEva (NASDAQ:OBSV) +9%. ProQR Th...
WARRINGTON, Pa., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has completed enrollment in its Phase 2 study ...
News, Short Squeeze, Breakout and More Instantly...
Windtree Therapeutics Inc. Company Name:
WINT Stock Symbol:
OTCMKTS Market:
Windtree Therapeutics Inc. Website:
$12.9 Million Transaction Includes Approximately $3.4 Million of New Funding and a $9.5 Million Full Cancellation of Outstanding Senior Notes and Extinguishment of Series B Preferred Shares The Company Also Established a $35 Million Equity Line of Credit WA...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...